The cAMP effectors, Rap2b and EPAC, are involved in the regulation of the development of the Coxiella burnetii containing vacuole by altering the fusogenic capacity of the vacuole.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 18 07 2018
accepted: 29 01 2019
entrez: 15 2 2019
pubmed: 15 2 2019
medline: 22 11 2019
Statut: epublish

Résumé

Cyclic Adenosine 3',5'-monophosphate (cAMP) is a key second messenger known to directly regulate not only the protein kinase A (PKA) activity but also other important molecules such as the exchange protein activated by cAMP (EPAC), which is as a guanine nucleotide exchange factor (GEF) of the low molecular weight GTPase, Rap2. Coxiella burnetii is a Gram negative bacterium that survives and grows in a large Coxiella replicative vacuole (CRV), which displays lysosomal and autophagic features. In this report, we present evidence that both, EPAC and its downstream effector Rap2b, were recruited to the CRV. The transient over-expression of the Rap2b wt protein, but not its inactive mutant Rap2b ΔAAX, markedly inhibited the development of the large CRV. Additionally, Rap2b wtinhibited the fusion of early Coxiella phagosomes with the fully developed CRV, indicating that homotypic fusion events are altered in the presence of high levels of Rap2b wt. Likewise, the fusion of endosome/lysosomal compartments (heterotypic fusions) with the large CRV was also affected by the over-expression of this GTPase. Interestingly, cell overexpression of Rap2b wt markedly decreased the levels of the v-SNARE, Vamp7, suggesting that this down-regulation impairs the homotypic and heterotypic fusions events of the Coxiella vacuole.

Identifiants

pubmed: 30763357
doi: 10.1371/journal.pone.0212202
pii: PONE-D-18-21333
pmc: PMC6375611
doi:

Substances chimiques

Guanine Nucleotide Exchange Factors 0
RAPGEF3 protein, human 0
Cyclic AMP E0399OZS9N
RAP2B protein, human EC 3.6.1.-
rap GTP-Binding Proteins EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0212202

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Front Cell Infect Microbiol. 2013 Sep 30;3:54
pubmed: 24137567
Infect Immun. 2011 Jan;79(1):402-13
pubmed: 20937765
J Bacteriol. 2004 Nov;186(21):7344-52
pubmed: 15489446
Dev Cell. 2004 Apr;6(4):463-77
pubmed: 15068787
Cell Microbiol. 2007 Apr;9(4):829-40
pubmed: 17381428
J Biol Chem. 2002 Jul 19;277(29):26581-6
pubmed: 12000763
Cell. 2004 Dec 17;119(6):753-66
pubmed: 15607973
Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):345-57
pubmed: 18176800
mBio. 2016 Jul 19;7(4):
pubmed: 27435465
Traffic. 2010 Sep;11(9):1246-61
pubmed: 20545908
PLoS One. 2013;8(1):e54566
pubmed: 23349930
mBio. 2013 Jan 29;4(1):e00606-12
pubmed: 23362322
PLoS Pathog. 2012;8(5):e1002664
pubmed: 22654658
Cell Microbiol. 2005 Jul;7(7):981-93
pubmed: 15953030
Trends Biochem Sci. 2006 Dec;31(12):680-6
pubmed: 17084085
PLoS One. 2014 Sep 09;9(9):e106687
pubmed: 25203140
Biochem Biophys Res Commun. 2009 Jan 23;378(4):732-7
pubmed: 19061864
J Cell Sci. 1994 Jun;107 ( Pt 6):1661-70
pubmed: 7962206
Biochim Biophys Acta. 2009 Dec;1793(12):1901-16
pubmed: 19781582
Biochim Biophys Acta. 2009 Apr;1788(4):790-6
pubmed: 19159611
J Cell Biol. 2010 Aug 23;190(4):533-9
pubmed: 20713600
J Biol Chem. 2012 Feb 10;287(7):5145-55
pubmed: 22194606
Cells. 2012 Jul 30;1(3):396-408
pubmed: 24710482
Cell Microbiol. 2013 Jun;15(6):922-41
pubmed: 23217169
J Bacteriol. 2013 Sep;195(17):3914-24
pubmed: 23813730
Curr Mol Med. 2011 Apr;11(3):197-203
pubmed: 21375493
Cell Microbiol. 2007 Apr;9(4):891-909
pubmed: 17087732
Nat Chem Biol. 2008 May;4(5):295-305
pubmed: 18391949
Br J Pharmacol. 2010 Jan 1;159(2):265-84
pubmed: 19912228
J Cell Sci. 2006 Sep 1;119(Pt 17):3686-94
pubmed: 16931599
Front Cell Infect Microbiol. 2017 Apr 24;7:112
pubmed: 28484683
J Biol Chem. 2009 Sep 11;284(37):24825-39
pubmed: 19546222
Curr Biol. 2005 Jul 26;15(14):R563-74
pubmed: 16051167
Infect Immun. 2014 Jun;82(6):2229-38
pubmed: 24643534
PLoS Pathog. 2014 Jul 31;10(7):e1004286
pubmed: 25080348
Infect Immun. 2002 Oct;70(10):5816-21
pubmed: 12228312

Auteurs

María Eugenia Mansilla Pareja (ME)

Laboratorio de Biología Celular y Molecular- Instituto de Histología y Embriología (IHEM)-Universidad Nacional de Cuyo, CONICET, Mendoza, Argentina.
Facultad de Ciencias Médicas, Mendoza, Argentina.
Facultad de Farmacia y Bioquímica, Universidad Juan Agustín Maza, Mendoza, Argentina.

Maria Celeste Gaurón (MC)

Laboratorio de Biología Celular y Molecular- Instituto de Histología y Embriología (IHEM)-Universidad Nacional de Cuyo, CONICET, Mendoza, Argentina.
Facultad de Ciencias Médicas, Mendoza, Argentina.

Esteban Robledo (E)

Laboratorio de Biología Celular y Molecular- Instituto de Histología y Embriología (IHEM)-Universidad Nacional de Cuyo, CONICET, Mendoza, Argentina.

Milton Osmar Aguilera (MO)

Laboratorio de Biología Celular y Molecular- Instituto de Histología y Embriología (IHEM)-Universidad Nacional de Cuyo, CONICET, Mendoza, Argentina.
Facultad de Odontología, UNCuyo, Mendoza, Argentina.

María Isabel Colombo (MI)

Laboratorio de Biología Celular y Molecular- Instituto de Histología y Embriología (IHEM)-Universidad Nacional de Cuyo, CONICET, Mendoza, Argentina.
Facultad de Ciencias Médicas, Mendoza, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH